Intravenous Tissue Plasminogen Activator Administration for Ischemic Stroke 1 Hour After Epidural Catheter Removal: A Case Report

Anne M. Baciewicz, Calvin Lee, Alon Ben-Ari, Hojoong Kim, Alex T. Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Anticoagulation after a recent neuraxial procedure poses risk for development of spinal hematoma. Clinical evidence supports prompt IV tissue plasminogen activator administration after onset of ischemic stroke. There is an absence of data regarding emergency fibrinolytic therapy for patients experiencing a stroke with recent neuraxial procedures, resulting in highly disparate, nonevidence-based guidelines. This report describes a patient who developed ischemic stroke when receiving postoperative epidural analgesia. Tissue plasminogen activator was emergently administered 1 hour after epidural catheter removal with a favorable recovery. The patient and his family reviewed the manuscript, and written consent to publish this case report was obtained from the patient.

Original languageEnglish (US)
Pages (from-to)113-115
Number of pages3
JournalA & A case reports
Volume8
Issue number5
DOIs
StatePublished - Mar 1 2017
Externally publishedYes

Fingerprint

Tissue Plasminogen Activator
Catheters
Stroke
Epidural Analgesia
Emergency Treatment
Manuscripts
Thrombolytic Therapy
Hematoma
Guidelines

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Intravenous Tissue Plasminogen Activator Administration for Ischemic Stroke 1 Hour After Epidural Catheter Removal : A Case Report. / Baciewicz, Anne M.; Lee, Calvin; Ben-Ari, Alon; Kim, Hojoong; Lee, Alex T.

In: A & A case reports, Vol. 8, No. 5, 01.03.2017, p. 113-115.

Research output: Contribution to journalArticle

@article{ca3767415dc74d51bc23a4044030c479,
title = "Intravenous Tissue Plasminogen Activator Administration for Ischemic Stroke 1 Hour After Epidural Catheter Removal: A Case Report",
abstract = "Anticoagulation after a recent neuraxial procedure poses risk for development of spinal hematoma. Clinical evidence supports prompt IV tissue plasminogen activator administration after onset of ischemic stroke. There is an absence of data regarding emergency fibrinolytic therapy for patients experiencing a stroke with recent neuraxial procedures, resulting in highly disparate, nonevidence-based guidelines. This report describes a patient who developed ischemic stroke when receiving postoperative epidural analgesia. Tissue plasminogen activator was emergently administered 1 hour after epidural catheter removal with a favorable recovery. The patient and his family reviewed the manuscript, and written consent to publish this case report was obtained from the patient.",
author = "Baciewicz, {Anne M.} and Calvin Lee and Alon Ben-Ari and Hojoong Kim and Lee, {Alex T.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1213/XAA.0000000000000443",
language = "English (US)",
volume = "8",
pages = "113--115",
journal = "A&A practice",
issn = "2325-7237",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Intravenous Tissue Plasminogen Activator Administration for Ischemic Stroke 1 Hour After Epidural Catheter Removal

T2 - A Case Report

AU - Baciewicz, Anne M.

AU - Lee, Calvin

AU - Ben-Ari, Alon

AU - Kim, Hojoong

AU - Lee, Alex T.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Anticoagulation after a recent neuraxial procedure poses risk for development of spinal hematoma. Clinical evidence supports prompt IV tissue plasminogen activator administration after onset of ischemic stroke. There is an absence of data regarding emergency fibrinolytic therapy for patients experiencing a stroke with recent neuraxial procedures, resulting in highly disparate, nonevidence-based guidelines. This report describes a patient who developed ischemic stroke when receiving postoperative epidural analgesia. Tissue plasminogen activator was emergently administered 1 hour after epidural catheter removal with a favorable recovery. The patient and his family reviewed the manuscript, and written consent to publish this case report was obtained from the patient.

AB - Anticoagulation after a recent neuraxial procedure poses risk for development of spinal hematoma. Clinical evidence supports prompt IV tissue plasminogen activator administration after onset of ischemic stroke. There is an absence of data regarding emergency fibrinolytic therapy for patients experiencing a stroke with recent neuraxial procedures, resulting in highly disparate, nonevidence-based guidelines. This report describes a patient who developed ischemic stroke when receiving postoperative epidural analgesia. Tissue plasminogen activator was emergently administered 1 hour after epidural catheter removal with a favorable recovery. The patient and his family reviewed the manuscript, and written consent to publish this case report was obtained from the patient.

UR - http://www.scopus.com/inward/record.url?scp=85015349762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015349762&partnerID=8YFLogxK

U2 - 10.1213/XAA.0000000000000443

DO - 10.1213/XAA.0000000000000443

M3 - Article

C2 - 28079666

AN - SCOPUS:85015349762

VL - 8

SP - 113

EP - 115

JO - A&A practice

JF - A&A practice

SN - 2325-7237

IS - 5

ER -